This press release details Revvity, Inc.'s financial results for the second quarter of 2025, highlighting revenue of $720 million and an adjusted EPS of $1.18 from continuing operations. The report breaks down performance by Life Sciences and Diagnostics segments, noting revenue increases in both. Furthermore, Revvity updated its full-year 2025 guidance, projecting revenue between $2.84 billion and $2.88 billion and adjusted EPS in the range of $4.85 to $4.95. The document also includes GAAP and non-GAAP financial reconciliations, alongside an explanation of the non-GAAP measures used to provide a clearer view of the company's ongoing operational performance. It concludes with information regarding a webcast for investors and important factors affecting future performance.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana